Pharmaceutical News

RSS

Cost-cutting measures are creeping into the medicine cabinet

Cost-cutting measures are creeping into the medicine cabinet. We split pills in half or take the drugs every other day to stretch our doses. We stop filling the prescriptions for our most expensive drugs. We buy prescriptions from online pharmacies with questionable credentials.

6 Apr 2009

Gilead Sciences announces notification of ANDA filing for Atripla

Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.

6 Apr 2009

BioDuro and Roche enter into strategic collaboration to provide drug discovery services

BioDuro has announced that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites.

6 Apr 2009

FDA warns 14 pharmaceutical companies about short internet ads lacking risk information

FDA has warned 14 major pharmaceutical firms about brief Internet advertisements that could have misled patients because they did not include information about health risks related to the drugs, according to letters posted to the agency's Web site Friday, the Wall Street Journal reports.

6 Apr 2009

'Well-fortified' drugstores have 'fighting chance' against government reform, Wall Street Journal says

Recent events in Washington state indicate that "well-fortified" pharmacy chains have a "fighting chance" as the health care industry gears up for "an assault of government reform," the Wall Street Journal reports.

6 Apr 2009

More consumers purchase vitamins, supplements amid economic recession

Sales of vitamins and nutritional supplements have surged in recent months as consumers look to avoid costly physician visits amid the ongoing economic recession, the New York Times reports.

6 Apr 2009

Nanobiotix reports 'proof of concept' for use of nanoparticles in treating glioblastoma multiforme

Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.

6 Apr 2009

Link between widely used osteoporosis drugs and heart problems probed

New research at Wake Forest University School of Medicine evaluated the link between a common class of drugs used to prevent bone fractures in osteoporosis patients and the development of irregular heartbeat.

6 Apr 2009

Zosano Pharma presents positive results for needle-free osteoporosis therapy

Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, has presented positive results from its phase 2 study of the ZP-PTH rapid delivery patch for the treatment of osteoporosis at the 8th International Symposium on Osteoporosis in Washington, D.C.

6 Apr 2009

Taro receives final FDA approval for Carbamazepine extended-release tablets

Taro Pharmaceutical Industries Ltd. has reported that it received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application ("ANDA") for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg ("carbamazepine extended-release tablets").

6 Apr 2009

U.S. FTC requests more information on Pfizer's proposed acquisition of Wyeth

Pfizer has announced that it has received a request for additional information from the U.S. Federal Trade Commission ("FTC") with respect to its previously announced proposed acquisition of Wyeth.

6 Apr 2009

Fluorescent anesthetic compound brings new avenues for drug discovery

A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs.

6 Apr 2009

Most psychiatrists who wrote clinical guidelines had financial ties to drug companies, study shows

Most of the psychiatrists on the American Psychiatric Association panels who wrote the newest clinical guidelines for how to treat depression, bipolar disorder and schizophrenia had financial ties to drug companies, according to a study by Boston researchers scheduled to be published this month in the journal Psychotherapy and Psychosomatics, the Boston Globe reports.

5 Apr 2009

Canadian Senator proposes process to expedite export of low-cost drugs for HIV, other diseases

Canadian Sen. Yoine Goldstein earlier this week proposed a bill that would reform Canada's Access to Medicines Regime by expediting the process of exporting generic drugs for diseases such as HIV to developing countries, the Ottawa Citizen reports.

5 Apr 2009

FDA warning letter to Genzyme related to the Allston facility

BioMarin Pharmaceutical Inc. has announced that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.

2 Apr 2009

FDA provides positive review of InNexus Biotechnology development plan for lead preclinical candidate

InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).

2 Apr 2009

FDA clears Cellectar's IND application for drug candidate

Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.

2 Apr 2009

Teva receives approval for generic Yaz (Drospirenone and Ethinyl Estradiol) tablets

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.

1 Apr 2009

FDA approves generic Topamax tablets (topiramate)

The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.

1 Apr 2009

Branding still overshadows critical fine print on nonprescription medications

Medicine packages barrage consumers with information, some required to be "prominent" and "conspicuous."

1 Apr 2009

Pharmaceutical News

Cost-cutting measures are creeping into the medicine cabinet

Gilead Sciences announces notification of ANDA filing for Atripla

BioDuro and Roche enter into strategic collaboration to provide drug discovery services

FDA warns 14 pharmaceutical companies about short internet ads lacking risk information

'Well-fortified' drugstores have 'fighting chance' against government reform, Wall Street Journal says

More consumers purchase vitamins, supplements amid economic recession

Nanobiotix reports 'proof of concept' for use of nanoparticles in treating glioblastoma multiforme

Link between widely used osteoporosis drugs and heart problems probed

Zosano Pharma presents positive results for needle-free osteoporosis therapy

Taro receives final FDA approval for Carbamazepine extended-release tablets

U.S. FTC requests more information on Pfizer's proposed acquisition of Wyeth

Fluorescent anesthetic compound brings new avenues for drug discovery

Most psychiatrists who wrote clinical guidelines had financial ties to drug companies, study shows

Canadian Senator proposes process to expedite export of low-cost drugs for HIV, other diseases

FDA warning letter to Genzyme related to the Allston facility

FDA provides positive review of InNexus Biotechnology development plan for lead preclinical candidate

FDA clears Cellectar's IND application for drug candidate

Teva receives approval for generic Yaz (Drospirenone and Ethinyl Estradiol) tablets

FDA approves generic Topamax tablets (topiramate)

Branding still overshadows critical fine print on nonprescription medications

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News